Mustang Bio, Inc.
MBIO
$1.54
-$0.11-6.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.28M | -10.71M | -15.75M | -23.42M | -32.06M |
| Total Depreciation and Amortization | 167.00K | 168.00K | 823.00K | 1.11M | 1.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.27M | 3.22M | 3.44M | 2.45M | 1.18M |
| Change in Net Operating Assets | -4.64M | -154.00K | 81.00K | 3.19M | 2.53M |
| Cash from Operations | -6.48M | -7.48M | -11.41M | -16.67M | -26.93M |
| Capital Expenditure | -- | -- | -- | -30.00K | -30.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | -- | 0.00 | 6.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -50.00K |
| Cash from Investing | 1.17M | 1.17M | -- | -30.00K | 5.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 14.34M | 19.61M | 12.04M | 10.88M | 9.97M |
| Repurchase of Common Stock | -235.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -775.00K | -775.00K | -775.00K | -591.00K | -445.00K |
| Cash from Financing | 13.33M | 18.83M | 11.27M | 10.29M | 9.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.01M | 12.52M | -145.00K | -6.41M | -11.49M |